Insider · CIK 0001778476
Abeliovich Asa
Reports to the SEC for 1 company · NEW YORK, NY
Transactions
10
Companies
1
Filings
3
CIK
0001778476
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2021-01-22 | Prevail Therapeutics Inc.U Disposition from Tender | — |
| 2021-01-22 | Prevail Therapeutics Inc.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2021-01-22 | Prevail Therapeutics Inc.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2021-01-22 | Prevail Therapeutics Inc.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2020-12-30 | Prevail Therapeutics Inc.M Exercise/Conversion | +$946.08 |
| 2020-12-30 | Prevail Therapeutics Inc.M Exercise/Conversion | +$1.24M |
| 2020-12-30 | Prevail Therapeutics Inc.F Tax Payment | −$2.05M |
| 2020-12-30 | Prevail Therapeutics Inc.Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2020-12-30 | Prevail Therapeutics Inc.Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2020-02-19 | Prevail Therapeutics Inc.Stock Option (Right to Buy)A Award | — |
Recent filings
- 4Abeliovich Asa0001209191-21-005459SEC(opens sec.gov)
- 4Abeliovich Asa0001209191-20-065696SEC(opens sec.gov)
- 4Abeliovich Asa0001209191-20-018121SEC(opens sec.gov)
Companies
Address
C/O PREVAIL THERAPEUTICS INC. 430 EAST 29TH STREET, SUITE 940
NEW YORK, NY, 10016